Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Miteva

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Molecular Genetics & Genomic Medicine|February 26, 2020
Analysis of protein missense alterations by combining sequence- and structure-based methodsAram Gyulkhandanyan, Alireza R Rezaie, Lubka Roumenina, et al.
Drug Discovery Today|October 4, 2016
Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolismAdriana Isvoran, Maxime Louet, Diana Larisa Vladoiu, et al.
Nucleic Acids Research|May 10, 2017
AMMOS2: a web server for protein-ligand-water complexes refinement via molecular mechanicsCéline M Labbé, Tania Pencheva, Dessislava Jereva, et al.
Chemmedchem|February 13, 2023
Ruthenium-Catalyzed Cycloaddition for Introducing Chemical Diversity in Second-Generation β-Lactamase InhibitorsFlavie Bouchet, Jean-Philippe Barnier, Ines Sayah, et al.
Current Pharmaceutical Biotechnology|April 9, 2008
In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeuticsBruno O Villoutreix, Karine Bastard, Olivier Sperandio, et al.
Scientific Reports|April 1, 2026
Mapping the inhibition landscape of P-glycoprotein via conformational ensemble dockingAhmad Elbahnsi, Cerasela Diana Dragomirescu, Nais Palumbo, et al.
Bioinformatics (Oxford, England)|August 29, 2015
Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6Virginie Y Martiny, Pablo Carbonell, Florent Chevillard, et al.
Plos One|May 11, 2018
Insights into molecular mechanisms of drug metabolism dysfunction of human CYP2C9*30Maxime Louet, Céline M Labbé, Charline Fagnen, et al.
International Journal of Molecular Sciences|September 25, 2019
A Free Web-Based Protocol to Assist Structure-Based Virtual Screening ExperimentsNathalie Lagarde, Elodie Goldwaser, Tania Pencheva, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2007
Design of protein membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor VKenneth Segers, Olivier Sperandio, Markus Sack, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Molecular Genetics & Genomic Medicine|February 26, 2020
Analysis of protein missense alterations by combining sequence- and structure-based methodsAram Gyulkhandanyan, Alireza R Rezaie, Lubka Roumenina, et al.
Drug Discovery Today|October 4, 2016
Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolismAdriana Isvoran, Maxime Louet, Diana Larisa Vladoiu, et al.
Nucleic Acids Research|May 10, 2017
AMMOS2: a web server for protein-ligand-water complexes refinement via molecular mechanicsCéline M Labbé, Tania Pencheva, Dessislava Jereva, et al.
Chemmedchem|February 13, 2023
Ruthenium-Catalyzed Cycloaddition for Introducing Chemical Diversity in Second-Generation β-Lactamase InhibitorsFlavie Bouchet, Jean-Philippe Barnier, Ines Sayah, et al.
Current Pharmaceutical Biotechnology|April 9, 2008
In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeuticsBruno O Villoutreix, Karine Bastard, Olivier Sperandio, et al.
Scientific Reports|April 1, 2026
Mapping the inhibition landscape of P-glycoprotein via conformational ensemble dockingAhmad Elbahnsi, Cerasela Diana Dragomirescu, Nais Palumbo, et al.
Bioinformatics (Oxford, England)|August 29, 2015
Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6Virginie Y Martiny, Pablo Carbonell, Florent Chevillard, et al.
Plos One|May 11, 2018
Insights into molecular mechanisms of drug metabolism dysfunction of human CYP2C9*30Maxime Louet, Céline M Labbé, Charline Fagnen, et al.
International Journal of Molecular Sciences|September 25, 2019
A Free Web-Based Protocol to Assist Structure-Based Virtual Screening ExperimentsNathalie Lagarde, Elodie Goldwaser, Tania Pencheva, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2007
Design of protein membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor VKenneth Segers, Olivier Sperandio, Markus Sack, et al.
Pageof 9